Open AccessAdditional rectal and sigmoid mucosal points and doses in high dose rate intracavitary brachytherapy for carcinoma cervix: A dosimetric study
Author(s) -
Umesh Mahantshetty,
Manpreet S. Tiwana,
Jamema Swamidas,
Shekhar Mishra,
Deepak D. Deshpande,
Shyamkishore Shrivastava
Publication year - 2011
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.87027
Subject(s) - brachytherapy , medicine , dose rate , cervix carcinoma , cervix , rectal carcinoma , nuclear medicine , radiology , rectum , radiation therapy , urology , cervical carcinoma , medical physics , colorectal cancer , cervical cancer , cancer
Late rectal and sigmoid toxicities seen in cervical cancer patients are attributed to brachytherapy despite rectal doses within tolerance limits. The purpose of this study was to identify additional dosimetric points which may better forecast rectal complications.